Melinda M Pettigrew1, Janneane F Gent2, Yong Kong3,4, Alison Laufer Halpin5, Lisa Pineles6, Anthony D Harris6, J Kristie Johnson6,7. 1. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut. 2. Department of Environmental Health Sciences, Yale School of Public Health, New Haven, Connecticut. 3. Department of Biostatistics, Yale School of Public Health, New Haven, Connecticut. 4. Department of Molecular Biophysics and Biochemistry, W. M. Keck Foundation Biotechnology Resource Laboratory, Yale School of Medicine, New Haven, Connecticut. 5. Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 6. Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore. 7. Department of Pathology, University of Maryland School of Medicine, Baltimore.
Abstract
BACKGROUND: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) colonizes the gastrointestinal tract of intensive care unit (ICU) patients, and CRPA colonization puts patients at increased risk of CRPA infection. Prior studies have not examined relationships between the microbiota, medications, and CRPA colonization acquisition. METHODS: Data and perirectal swabs were obtained from a cohort of ICU patients at the University of Maryland Medical Center. Patients (N = 109) were classified into 3 groups by CRPA colonization-acquisition status and antimicrobial exposure. We conducted 16S ribosomal RNA gene sequencing of an ICU admission swab and ≥1 additional swab and evaluated associations between patient characteristics, medications, the gastrointestinal microbiota, and CRPA colonization acquisition. RESULTS: ICU patients had low levels of diversity and high relative abundances of pathobionts. Piperacillin-tazobactam was prescribed more frequently to patients with CRPA colonization acquisition than those without. Piperacillin-tazobactam was associated with low abundance of potentially protective taxa (eg, Lactobacillus and Clostridiales) and increased risk of Enterococcus domination (odds ratio [OR], 5.50; 95% confidence interval [CI], 2.03-14.92). Opioids were associated with dysbiosis in patients who did not receive antibiotics; potentially protective Blautia and Lactobacillus were higher in patients who did not receive opioids. Several correlated taxa, identified at ICU admission, were associated with lower risk of CRPA colonization acquisition (OR, 0.58; 95% CI, .38-.87). CONCLUSIONS: Antibiotics differed in their impact on the microbiota, with piperacillin-tazobactam being particularly damaging. Certain bacterial taxa (eg, Clostridiales) were negatively associated with CRPA colonization acquisition. These taxa may be markers of risk for CRPA colonization acquisition and/or serve a protective role.
BACKGROUND:Carbapenem-resistant Pseudomonas aeruginosa (CRPA) colonizes the gastrointestinal tract of intensive care unit (ICU) patients, and CRPA colonization puts patients at increased risk of CRPA infection. Prior studies have not examined relationships between the microbiota, medications, and CRPA colonization acquisition. METHODS: Data and perirectal swabs were obtained from a cohort of ICU patients at the University of Maryland Medical Center. Patients (N = 109) were classified into 3 groups by CRPA colonization-acquisition status and antimicrobial exposure. We conducted 16S ribosomal RNA gene sequencing of an ICU admission swab and ≥1 additional swab and evaluated associations between patient characteristics, medications, the gastrointestinal microbiota, and CRPA colonization acquisition. RESULTS: ICU patients had low levels of diversity and high relative abundances of pathobionts. Piperacillin-tazobactam was prescribed more frequently to patients with CRPA colonization acquisition than those without. Piperacillin-tazobactam was associated with low abundance of potentially protective taxa (eg, Lactobacillus and Clostridiales) and increased risk of Enterococcus domination (odds ratio [OR], 5.50; 95% confidence interval [CI], 2.03-14.92). Opioids were associated with dysbiosis in patients who did not receive antibiotics; potentially protective Blautia and Lactobacillus were higher in patients who did not receive opioids. Several correlated taxa, identified at ICU admission, were associated with lower risk of CRPA colonization acquisition (OR, 0.58; 95% CI, .38-.87). CONCLUSIONS: Antibiotics differed in their impact on the microbiota, with piperacillin-tazobactam being particularly damaging. Certain bacterial taxa (eg, Clostridiales) were negatively associated with CRPA colonization acquisition. These taxa may be markers of risk for CRPA colonization acquisition and/or serve a protective role.
Authors: James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss Journal: Appl Environ Microbiol Date: 2013-06-21 Impact factor: 4.792
Authors: Rafael Araos; Albert K Tai; Graham M Snyder; Martin J Blaser; Erika M C D'Agata Journal: Clin Infect Dis Date: 2016-06-28 Impact factor: 9.079
Authors: J Kristie Johnson; Gwen Smith; Mary S Lee; Richard A Venezia; O Colin Stine; James P Nataro; William Hsiao; Anthony D Harris Journal: J Infect Dis Date: 2009-09-15 Impact factor: 5.226
Authors: Floris Imhann; Marc Jan Bonder; Arnau Vich Vila; Jingyuan Fu; Zlatan Mujagic; Lisa Vork; Ettje F Tigchelaar; Soesma A Jankipersadsing; Maria Carmen Cenit; Hermie J M Harmsen; Gerard Dijkstra; Lude Franke; Ramnik J Xavier; Daisy Jonkers; Cisca Wijmenga; Rinse K Weersma; Alexandra Zhernakova Journal: Gut Date: 2015-12-09 Impact factor: 23.059
Authors: Jiye Kwon; Yong Kong; Martina Wade; Derek J Williams; Clarence Buddy Creech; Scott Evans; Emmanuel B Walter; Judy M Martin; Jeffrey S Gerber; Jason G Newland; Meghan E Hofto; Mary Allen Staat; Henry F Chambers; Vance G Fowler; W Charles Huskins; Melinda M Pettigrew Journal: J Infect Dis Date: 2022-09-21 Impact factor: 7.759
Authors: Medini K Annavajhala; Angela Gomez-Simmonds; Nenad Macesic; Sean B Sullivan; Anna Kress; Sabrina D Khan; Marla J Giddins; Stephania Stump; Grace I Kim; Ryan Narain; Elizabeth C Verna; Anne-Catrin Uhlemann Journal: Nat Commun Date: 2019-10-17 Impact factor: 14.919
Authors: Felix C F Schmitt; Martin Schneider; William Mathejczyk; Markus A Weigand; Jane C Figueiredo; Christopher I Li; David Shibata; Erin M Siegel; Adetunji T Toriola; Cornelia M Ulrich; Alexis B Ulrich; Sébastien Boutin; Biljana Gigic Journal: Life (Basel) Date: 2021-03-16